Scarica l'app Stockscreener
5.53
6.43%
-0.38
Dopo l'orario di chiusura:
5.50
-0.03
-0.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABCL Giù?
Forum
Previsione
Precedente Chiudi:
$5.91
Aprire:
$5.91
Volume 24 ore:
7.18M
Relative Volume:
1.27
Capitalizzazione di mercato:
$1.65B
Reddito:
$38.03M
Utile/perdita netta:
$-146.40M
Rapporto P/E:
-10.63
EPS:
-0.52
Flusso di cassa netto:
$-121.38M
1 W Prestazione:
-6.27%
1M Prestazione:
+29.21%
6M Prestazione:
+167.15%
1 anno Prestazione:
+121.20%
Intervallo 1D:
$5.46
$5.9366
Intervallo di 1 settimana:
$5.46
$6.515
Portata 52W:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Nome
Abcellera Biologics Inc
Settore
Industria
Telefono
(604) 559-9005
Indirizzo
150 W 4TH AVENUE, VANCOUVER
Confronta ABCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.53 | 1.77B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Ripresa | Leerink Partners | Outperform |
| 2024-08-20 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Ripresa | Piper Sandler | Overweight |
| 2023-02-28 | Iniziato | Cowen | Outperform |
| 2022-12-15 | Iniziato | Goldman | Buy |
| 2022-11-16 | Iniziato | Truist | Buy |
| 2021-12-21 | Iniziato | The Benchmark Company | Buy |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2021-01-05 | Iniziato | Berenberg | Buy |
| 2021-01-05 | Iniziato | Credit Suisse | Outperform |
| 2021-01-05 | Iniziato | SVB Leerink | Outperform |
| 2021-01-05 | Iniziato | Stifel | Buy |
Mostra tutto
Abcellera Biologics Inc Borsa (ABCL) Ultime notizie
AbCellera Biologics Hits New 52-Week High of $6.51 - Markets Mojo
Is now a turning point for AbCellera Biologics Inc.Earnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Why AbCellera Biologics Inc. (8QQ) stock could rally stronglyNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
Analyzing AbCellera Biologics Inc. with risk reward ratio chartsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Custom watchlist performance reports with AbCellera Biologics Inc.2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Real time alert setup for AbCellera Biologics Inc. performanceStop Loss & Weekly High Potential Stock Alerts - newser.com
Does AbCellera Biologics Inc. qualify in momentum factor screening2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Is AbCellera Biologics Inc. (8QQ) stock cheap vs fundamentalsWeekly Trend Report & Safe Swing Trade Setups - newser.com
Is AbCellera Biologics Inc. (8QQ) stock a top dividend aristocrat candidateEarnings Beat & Expert Curated Trade Setups - newser.com
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 - PharmiWeb.com
AbCellera Biologics: Entering Growth Phase After A Pause (NASDAQ:ABCL) - Seeking Alpha
AbCellera Biologics Inc. recovery potential after sell off2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Is AbCellera Biologics Inc. stock a dividend growth opportunity2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Forecasting AbCellera Biologics Inc. price range with options dataJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Should you hold or exit AbCellera Biologics Inc. nowWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Statistical indicators supporting AbCellera Biologics Inc.’s strengthQuarterly Market Review & Fast Gaining Stock Reports - newser.com
How AbCellera Biologics Inc. (8QQ) stock behaves in tightening cyclesEarnings Miss & Real-Time Volume Triggers - newser.com
Leading vs lagging indicators on AbCellera Biologics Inc. performanceTrade Exit Summary & Short-Term High Return Ideas - newser.com
Is AbCellera Biologics Inc. stock safe for conservative investors2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
How AbCellera Biologics Inc. stock benefits from tech adoption2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
Published on: 2025-10-05 03:44:08 - newser.com
AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price - Markets Mojo
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline - Yahoo
How high can AbCellera Biologics Inc. stock goRate Cut & Technical Pattern Recognition Alerts - newser.com
Using RSI to spot recovery in AbCellera Biologics Inc.Trade Volume Summary & Advanced Technical Analysis Signals - newser.com
Published on: 2025-10-03 03:02:14 - newser.com
Is AbCellera Biologics Inc. (8QQ) stock in buy zone after pullback2025 Historical Comparison & AI Driven Stock Movement Reports - newser.com
Published on: 2025-10-03 00:01:15 - newser.com
Abcellera Biologics Inc Azioni (ABCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):